Literature DB >> 30064124

Natural History of Cervical Artery Fibromuscular Dysplasia and Associated Neurovascular Events.

Daniella Kadian-Dodov, Judith Z Goldfinger, Susan Gustavson, Jeffrey W Olin.   

Abstract

BACKGROUND AND
PURPOSE: Fibromuscular dysplasia (FMD) is a non-atherosclerotic arteriopathy most often affecting the carotid and renal arteries. In the United States Registry for FMD, 41.7% of patients experienced an aneurysm and/or dissection by the time of entry into the Registry. We sought to determine the occurrence of neurovascular events after FMD diagnosis and any changes on cervical artery imaging that may be attributable to FMD.
METHODS: Patients followed at the Mount Sinai Medical Center (US Registry for FMD enrollment center) with confirmed FMD and > 1 cervical artery imaging study (at least ± 6 months from the baseline carotid duplex ultrasound [CDU]) between the years 2003 and 2015 were included. Medical records and cervical artery imaging ([CDU], magnetic resonance angiogram [MRA], and computed tomography angiogram [CTA]) were reviewed. New arterial dissection, aneurysm, transient ischemic attack, stroke, or new FMD findings were recorded.
RESULTS: Among 146 FMD patients with complete information, 52 (35.6%) had an aneurysm and 52 (35.6%) had a dissection. Mean clinical follow-up was 35.3 ± 25.3 months (range 5-153 months); patients underwent 4 ± 2.7 CDU (range 1-17); 86.3% had ≥1 neck MRA or CTA. After FMD diagnosis, 3 patients (2%) experienced a new carotid artery dissection; 1 patient experienced a stroke due to concomitant atherosclerosis. No new aneurysms occurred. In patients with cervical artery FMD, imaging findings remained stable throughout follow-up. No patient developed new cervical artery FMD findings on follow-up imaging.
CONCLUSIONS: No new cervical artery FMD or aneurysm was observed on subsequent imaging. New carotid dissection was uncommon over a mean follow-up period of 35.3 ± 25.3 months and was the only non-atherosclerotic vascular event observed after FMD diagnosis.
© 2018 S. Karger AG, Basel.

Entities:  

Keywords:  Carotid artery; Dissection; Fibromuscular dysplasia; Internal; Natural history; Stroke

Mesh:

Year:  2018        PMID: 30064124     DOI: 10.1159/000491437

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  5 in total

Review 1.  Current progress in clinical, molecular, and genetic aspects of adult fibromuscular dysplasia.

Authors:  Alexandre Persu; Piotr Dobrowolski; Heather L Gornik; Jeffrey W Olin; David Adlam; Michel Azizi; Pierre Boutouyrie; Rosa Maria Bruno; Marion Boulanger; Jean-Baptiste Demoulin; Santhi K Ganesh; Tomasz J Guzik; Magdalena Januszewicz; Jason C Kovacic; Mariusz Kruk; Peter de Leeuw; Bart L Loeys; Marco Pappaccogli; Melanie H A M Perik; Emmanuel Touzé; Patricia Van der Niepen; Daan J L Van Twist; Ewa Warchoł-Celińska; Aleksander Prejbisz; Andrzej Januszewicz
Journal:  Cardiovasc Res       Date:  2022-01-07       Impact factor: 10.787

2.  Prevalence of Cervical Artery Abnormalities on CTA in Patients with Spontaneous Coronary Artery Dissection: Fibromuscular Dysplasia, Dissection, Aneurysm, and Tortuosity.

Authors:  J C Benson; V T Lehman; J T Verdoorn; D P Shlapak; S N Hayes; M S Tweet
Journal:  AJNR Am J Neuroradiol       Date:  2021-05-13       Impact factor: 4.966

3.  Casper stent in the treatment of pulsatile tinnitus in fibromuscular dysplasia: Therapeutic review and case report.

Authors:  José Ricardo Vanzin; Artur Eduardo Martio; Luciano Bambini Manzato; Daniel Giansante Abud
Journal:  Brain Circ       Date:  2021-12-21

4.  FMD and SCAD: Sex-Biased Arterial Diseases With Clinical and Genetic Pleiotropy.

Authors:  Esther S H Kim; Jacqueline Saw; Daniella Kadian-Dodov; Malissa Wood; Santhi K Ganesh
Journal:  Circ Res       Date:  2021-06-10       Impact factor: 23.213

5.  Different clinical courses of various radiologic findings in fibromuscular dysplasia during a 7-year follow-up: A case report.

Authors:  Sangil Park; Hye-Yeon Choi
Journal:  Medicine (Baltimore)       Date:  2020-07-10       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.